Vera Therapeutics price objective cut to $60 from $66
VERA•BofA Global Research cut its price objective for Vera Therapeutics to $60 from $66.
Related News
Axia Energia director Pedro Batista de Lima Filho sells $9.63 million in common shares
EBR•
Tesla renames 'Full Self-Driving' to 'Assisted Driving' in Europe as it seeks software clearance
TSLA•
Nasdaq trade halt: volatility trading pause at 10:06 a.m.
GSIW•
Bank of America names Jeff Crabtree president of Sarasota/Manatee market
BAC•
Nasdaq trade halt: volatility trading pause at 10:08 a.m.
AIOK•